- Home
- BMRN vs DOX Comparison
BMRN vs DOX Comparison
Compare BMRN & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- DOX
- Stock Information
- Founded
- BMRN 1996
- DOX 1982
- Country
- BMRN United States
- DOX United States
- Employees
- BMRN N/A
- DOX N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- DOX EDP Services
- Sector
- BMRN Health Care
- DOX Technology
- Exchange
- BMRN Nasdaq
- DOX Nasdaq
- Market Cap
- BMRN 12.1B
- DOX 9.9B
- IPO Year
- BMRN 1999
- DOX 1998
- Fundamental
- Price
- BMRN $59.82
- DOX $93.24
- Analyst Decision
- BMRN Buy
- DOX Strong Buy
- Analyst Count
- BMRN 22
- DOX 5
- Target Price
- BMRN $93.43
- DOX $101.20
- AVG Volume (30 Days)
- BMRN 1.6M
- DOX 632.0K
- Earning Date
- BMRN 05-01-2025
- DOX 05-07-2025
- Dividend Yield
- BMRN N/A
- DOX 2.28%
- EPS Growth
- BMRN 152.82
- DOX 6.51
- EPS
- BMRN 2.71
- DOX 4.75
- Revenue
- BMRN $2,950,227,000.00
- DOX $4,752,199,000.00
- Revenue This Year
- BMRN $12.27
- DOX N/A
- Revenue Next Year
- BMRN $9.86
- DOX $4.36
- P/E Ratio
- BMRN $22.11
- DOX $18.82
- Revenue Growth
- BMRN 19.36
- DOX N/A
- 52 Week Low
- BMRN $52.93
- DOX $74.41
- 52 Week High
- BMRN $94.85
- DOX $93.34
- Technical
- Relative Strength Index (RSI)
- BMRN 40.34
- DOX 58.42
- Support Level
- BMRN $60.92
- DOX $88.68
- Resistance Level
- BMRN $65.40
- DOX $87.01
- Average True Range (ATR)
- BMRN 1.96
- DOX 1.64
- MACD
- BMRN 0.06
- DOX 0.67
- Stochastic Oscillator
- BMRN 21.52
- DOX 83.52
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.